日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

A phase 2 study of zanubrutinib in combination with rituximab and lenalidomide in de novo diffuse large B-cell lymphoma.

一项针对新发弥漫性大B细胞淋巴瘤的 2 期研究，评估 zanubrutinib 与利妥昔单抗和来那度胺联合用药的疗效。

期刊:Blood
影响因子:23.1
doi:10.1182/blood.2025028649
Xu Peng-Peng, Zhu Yue, Shi Zi-Yang, Wang Li, Cheng Shu, Qian Ying, Zhao Yan, He Yang, Yi Hong-Mei, Ou-Yang Bin-Shen, Jiang Xu-Feng, Li Biao, Song Qi, Mu Rong-Ji, Zhao Wei-Li
淋巴瘤
细胞生物学
B细胞
发表日期：2025
文献求助 收藏

Clinical characteristics and molecular heterogeneity in Follicular lymphoma with extranodal involvement

滤泡性淋巴瘤伴结外侵犯的临床特征和分子异质性

期刊:Genome Medicine
影响因子:11.2
doi:10.1186/s13073-025-01557-y
Li, Rui-Chi; Tang, Wei; Zhang, Hui-Lai; Wang, Xian-Huo; Sun, Rui; Wang, Nan; Xu, Tian-Yuan; Chen, Si-Yuan; Feng, Yan; Shen, Rong; Wang, Li; Cheng, Shu; Xu, Peng-Peng; Yi, Hong-Mei; Dong, Lei; Zheng, Zhong; Zhao, Wei-Li
淋巴瘤
发表日期：2025
文献求助 收藏

Molecular heterogeneity of CD30(+) peripheral T-cell lymphoma with prognostic significance and therapeutic implications: a retrospective multi-centre study

CD30(+)外周T细胞淋巴瘤的分子异质性及其预后意义和治疗策略：一项回顾性多中心研究

期刊:EBioMedicine
影响因子:10.8
doi:10.1016/j.ebiom.2025.105693
Huo, Yu-Jia; Cheng, Shu; Yi, Hong-Mei; Niu, Ting; Fan, Lei; Cui, Guo-Hui; Zhou, Fu-Ling; Song, Xian-Min; Li, Fei; Bai, Ou; Yan, Xiao-Jing; Shi, Jun; Cai, Ming-Ci; Huang, Yao-Hui; Dong, Lei; Xiong, Jie; Hu, Song; Qiu, Yu-Ran; Zhao, Yan; Xu, Peng-Peng; Wang, Li; Lu, Min; Jing, Hong-Mei; Zhao, Wei-Li
T细胞
淋巴瘤
CD30
CD3
T细胞
细胞生物学
免疫/内分泌
发表日期：2025
文献求助 收藏

A prognostic index integrating deep learning baseline PET/CT biomarkers and multi-omics profiling in diffuse large B cell lymphoma

弥漫性大B细胞淋巴瘤预后指数：整合深度学习基线PET/CT生物标志物和多组学分析

期刊:Cell Reports Medicine
影响因子:10.6
doi:10.1016/j.xcrm.2025.102452
Wang, Yue; Wang, Xue; Huang, Xin-Yun; Jing, Hong-Mei; Jiang, Song-Fu; Li, He; Mu, Rong-Ji; Shi, Qing; Fu, Di; Li, Zhuo-Han; Yi, Hong-Mei; Ouyang, Bin-Shen; Li, Biao; Yan, Fu-Hua; Niu, Ting; Cheng, Shu; Wang, Li; Wen, Ning; Xu, Peng-Peng; Zhao, Wei-Li
B细胞
细胞生物学
淋巴瘤
免疫/内分泌
发表日期：2025
文献求助 收藏

Practical microenvironment classification in diffuse large B cell lymphoma using digital pathology.

利用数字病理学对弥漫性大B细胞淋巴瘤的微环境进行实用分类

期刊:Cell Reports Medicine
影响因子:10.6
doi:10.1016/j.xcrm.2025.102030
Wang Yu-Qing, Wang Shuo, Yi Hong-Mei, Qian Ying, Wang Yue, Xu Hai-Min, Xu-Monette Zijun Y, Au Kelly, Tian Shuang, Dong Yan, Zhao Jing, Fu Di, Mu Rong-Ji, Wang Shu-Ye, Wang Li, Young Ken H, Xu Peng-Peng, Zhao Wei-Li
细胞生物学
发表日期：2025
文献求助 收藏

Clinicopathological characteristics, genetic aberrations, and optimized treatment strategies in double-hit and triple-hit lymphoma: a multi-center cohort study

双重打击和三重打击淋巴瘤的临床病理特征、基因异常和优化治疗策略：一项多中心队列研究

期刊:Molecular Biomedicine
影响因子:10.1
doi:10.1186/s43556-025-00346-8
Shen, Yi-Ge; Ji, Meng-Meng; Shi, Qing; Wei, Xiao-Lei; Fan, Lei; Liu, Ting-Bo; Liu, Yao; Dong, Li-Hua; Liang, Ai-Bin; Huang, Liang; Zhou, Hui; Huang, Hong-Hui; Yang, Shen-Miao; Wang, Xiao-Bo; Tian, Yu-Yang; Zhu, Zun-Min; Bai, Ou; Li, Fei; Shi, Wen-Yu; Xu, Bin; Wang, Xin; Shi, Ke-Qian; Tang, Wei; Yi, Hong-Mei; Chen, Si-Yuan; Zheng, Zhong; Cheng, Shu; Xu, Peng-Peng; Zhao, Wei-Li; Wang, Li
淋巴瘤
发表日期：2025
文献求助 收藏

Retraction Note: Annexin A1-suppressed autophagy promotes nasopharyngeal carcinoma cell invasion and metastasis by PI3K/AKT signaling activation

撤稿声明：Annexin A1抑制的自噬通过PI3K/AKT信号通路激活促进鼻咽癌细胞侵袭和转移。

期刊:Cell Death & Disease
影响因子:9.6
doi:10.1038/s41419-025-07540-0
Zhu, Jin-Feng; Huang, Wei; Yi, Hong-Mei; Xiao, Ta; Li, Jiao-Yang; Feng, Juan; Yi, Hong; Lu, Shan-Shan; Li, Xin-Hui; Lu, Rou-Huang; He, Qiu-Yan; Xiao, Zhi-Qiang
肿瘤
肿瘤免疫
信号转导
Annexin A1
鼻咽癌
细胞生物学
AKT
自噬
发表日期：2025
文献求助 收藏

Response-adapted zanubrutinib and tislelizumab as a potential strategy to enhance CD19 CAR T-cell therapy in relapsed/refractory large B-cell lymphoma: A retrospective observational study.

反应适应性 zanubrutinib 和 tislelizumab 作为增强 CD19 CAR T 细胞疗法治疗复发/难治性大 B 细胞淋巴瘤的潜在策略：一项回顾性观察研究

期刊:Clinical and Translational Medicine
影响因子:6.8
doi:10.1002/ctm2.70310
Shen Rong, Cao Wei-Guo, Wang Li, Sheng Ling-Shuang, Zhang Yi-Lun, Wu Wen, Xu Peng-Peng, Cheng Shu, Liu Meng-Ke, Dong Yan, Wang Yue, Weng Xiang-Qin, Jiang Xu-Feng, Song Qi, Yi Hong-Mei, Li Lei, Chen Sheng, Yan Zi-Xun, Zhao Wei-Li
细胞生物学
发表日期：2025
文献求助 收藏

Binding Sites of a PET Ligand in Tau Fibrils with the Alzheimer's Disease Fold from (19)F and (13)C Solid-State NMR

利用 (19)F 和 (13)C 固态核磁共振研究阿尔茨海默病折叠 Tau 蛋白原纤维中 PET 配体的结合位点。

期刊:Biochemistry
影响因子:3
doi:10.1021/acs.biochem.5c00016
Angehrn, Frida N; Duan, Pu; Zhang, Jia Yi; Hong, Mei
阿尔茨海默症
发表日期：2025
文献求助 收藏

Anti-metabolic agent pegaspargase plus PD-1 antibody sintilimab for first-line treatment in advanced natural killer T cell lymphoma

抗代谢药物培门冬酶联合PD-1抗体信迪利单抗用于晚期自然杀伤T细胞淋巴瘤的一线治疗

期刊:Signal Transduction and Targeted Therapy
影响因子:52.7
doi:10.1038/s41392-024-01782-8
Xiong, Jie; Cheng, Shu; Gao, Xiao; Yu, Shan-He; Dai, Yu-Ting; Huang, Xin-Yun; Zhong, Hui-Juan; Wang, Chao-Fu; Yi, Hong-Mei; Zhang, Hao; Cao, Wei-Guo; Li, Rong; Tang, Wei; Zhao, Yan; Xu, Peng-Peng; Wang, Li; Zhao, Wei-Li
T细胞
淋巴瘤
代谢
T细胞
细胞生物学
PD-1
免疫/内分泌
发表日期：2024
文献求助 收藏